Indusatumab vedotin
Product Specifications
Target
Others|||Antibody-Drug Conjugates (ADCs) |||Apoptosis|||Guanylate cyclase
Related Pathways
GPCR/G Protein|||Apoptosis|||Antibody-drug Conjugate/ADC Related|||Others
Bioactivity
Indusatumab vedotin (MLN-0264; AKT-264) is an antibody-drug conjugate (ADC) that combines a human anti-guanylate cyclase C (GCC) antibody with the microtubule-disruptor monomethyl auristatin E, demonstrating anti-proliferative effects on pancreatic cancer cell lines by arresting the cell cycle at the G2/M phase and inducing apoptosis [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/187269689313853452/T9901A-023
CAS Number
1514889-12-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items